Telehealth Weight Loss · Serving NY & CT Only

Medical Weight Loss That Respects Your Biology – In New York & Connecticut

Serving New York and Connecticut with GLP-1–based therapy combined with structured clinical nutrition to support sustainable fat loss, metabolic health, and long-term results.

Semaglutide from $550/mo Tirzepatide from $600/mo Clinical nutrition support Medical oversight

Start Your Medical Weight Loss Evaluation

Treatment recommendations are determined after clinical evaluation. This page is informational and does not establish a provider–patient relationship.

Shatika James, DNP, FNP-BC Doctor of Nursing Practice

How this is different

Not another “weight loss program.” A clinician-guided metabolic strategy.

GLP-1 medications influence hormonal drivers of appetite and glucose regulation. Your plan pairs GLP-1 therapy with structured nutrition support to protect lean mass, improve adherence, and support durability.

GLP-1 therapy options

Choose the right tool. Pair it with the right nutrition strategy.

Medication selection is individualized based on clinical history, available labs, and response.

Semaglutide Program

GLP-1 therapy + clinical nutrition support

Starting at $550 / month

• Eligibility evaluation
• Dosing strategy guidance
• Side-effect support
• Nutrition structure and follow-through

Tirzepatide Program

Dual-agonist support + clinical nutrition

Starting at $600 / month

• Eligibility evaluation
• Dosing strategy guidance
• Side-effect support
• Nutrition structure and follow-through

Pricing shown reflects starting offers. Final plan structure depends on clinical evaluation.

Assessment process

Clear input → telehealth visit → clear plan → clear follow-through.

Submit

Complete intake and share any available labs.

Review

Your clinical picture is assessed for fit and safety.

Telehealth Visit

Goals, plan, and expectations are confirmed.

Plan

You receive a medication + nutrition strategy.

Start Your Medical Weight Loss Evaluation

Ready to start?

Begin with an evaluation so we can choose the best-fit plan.

Start Your Medical Weight Loss Evaluation

Telehealth services available for NY & CT residents. You must be located in NY or CT at the time of the visit.

^† Ozempic®, WeGovy®, Saxenda®, and Victoza® are registered trademarks of Novo Nordisk. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly. Òmni Health NP is not affiliated with Novo Nordisk or Eli Lilly, and the compounded products offered by Òmni Health NP are not produced by these companies. Compounded medications may be prescribed based on personal weight loss needs. While federal law allows the prescription of compounded drugs, they are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review.

The information provided on this website is for informational purposes and not a substitute for professional medical advice, diagnosis, or treatment. If you have questions or concerns about your health, please talk to your medical provider. This site is an advertisement for services and not any specific medication.